# Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians

> **NCT02029547** · NA · WITHDRAWN · sponsor: **Avid Radiopharmaceuticals**

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Florbetapir (18F)

## Key facts

- **NCT ID:** NCT02029547
- **Lead sponsor:** Avid Radiopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-10
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2014-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02029547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02029547, "Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02029547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*